• For Researchers

The microbiome and cancer: what’s all the fuss about?

Researchers are increasingly interested in the link between cancer and the microbiome. We take a look at what's happening in this rapidly developing field. Researchers are increasingly interested in the link between cancer and the microbiome. We take a look at what's happening in this rapidly developing field.

13 June 2017

• Science & Technology
• Health & Medicine

News digest – Improving prostate cancer survival, a life-extending app, yoga and... a tribute to Professor Patrick Johnston.

Improving prostate cancer survival, a life-extending app, yoga and our tribute to the remarkable Professor Patrick Johnston. Here’s our weekly news report. Improving prostate cancer survival, a life-extending app, yoga and our tribute to the remarkable Professor Patrick Johnston. Here’s our weekly news report.

10 June 2017

• Science & Technology

Certain genetic faults could help predict success of immunotherapy

A certain group of genetic faults could be used to help predict if immunotherapy will work in cancer patients, according to a new US study. A certain group of genetic faults could be used to help predict if immunotherapy will work in cancer patients, according to a new US study.

9 June 2017

• For Researchers

Exploring a new direction in immunotherapy

Dr Edd James, an established immunologist, is taking his first steps into drug discovery with funding from our Small Molecule Project Award. Dr Edd James, an established immunologist, is taking his first steps into drug discovery with funding from our Small Molecule Project Award.

8 June 2017

• For Researchers

Understanding early evolution of hard to treat cancer

Dr Phil Jones is using Programme Award funding to explore the earliest steps in the evolution of oesophageal cancer. Dr Phil Jones is using Programme Award funding to explore the earliest steps in the evolution of oesophageal cancer.

8 June 2017

• Health & Medicine

Combining immunotherapies could benefit some aggressive breast cancers

Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study. Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.

8 June 2017

• Science & Technology
• Health & Medicine

‘Once in a career feeling’ as trial shows offering prostate cancer drug earlier improves survival

We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer. We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer.

6 June 2017

• Health & Medicine

New chemotherapy approach offers breast cancer patients a better quality of life

The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF

6 June 2017

• Health & Medicine

Two clinical trials show promise with different targeted drugs for lung cancer

Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available. Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available.

6 June 2017

• Charity News

Statement on the death of Professor Patrick Johnston

Cancer Research UK statement on the death of Professor Patrick Johnston in Belfast. Cancer Research UK statement on the death of Professor Patrick Johnston in Belfast.

5 June 2017

• Health & Medicine

Ovarian cancer drug reduces chance certain advanced breast cancers will get worse

A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy. A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.

4 June 2017

• Health & Medicine

Combined immunotherapy could help control melanoma that has spread to the brain

A combination of two immunotherapy drugs is safe to give to patients with melanoma that has spread to the brain, and could help control the disease. A combination of two immunotherapy drugs is safe to give to patients with melanoma that has spread to the brain, and could help control the disease.

4 June 2017